Promising CNS-directed Enzyme Replacement Therapy for Lysosomal Storage Diseases

Experimental Neurology - United States
doi 10.1016/j.expneurol.2009.03.040
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Fetal Gene Therapy for Neurodegenerative Lysosomal Storage Diseases

Journal of Inherited Metabolic Disease
Genetics
2019English

Immune Response Hinders Therapy for Lysosomal Storage Diseases

Journal of Clinical Investigation
Medicine
2008English

Genetic Substrate Reduction Therapy: A Promising Approach for Lysosomal Storage Disorders

Diseases
2016English

Brain Endothelium as a Site for CNS-directed Enzyme Therapy

Science-Business eXchange
2009English

Publisher Correction: Lysosomal Storage Diseases

Nature Reviews Disease Primers
Medicine
2019English

Engineering of GlcNAc-1-Phosphotransferase for Production of Highly Phosphorylated Lysosomal Enzymes for Enzyme Replacement Therapy

Molecular Therapy - Methods and Clinical Development
Molecular MedicineGeneticsMolecular Biology
2017English

Neuroinflammatory Paradigms in Lysosomal Storage Diseases

Frontiers in Neuroscience
Neuroscience
2015English

Lysosomal Storage Diseases—Regulating Neurodegeneration

Journal of Experimental Neuroscience
Neuroscience
2015English

Gene Therapy for CNS Diseases – Krabbe Disease

BioImpacts
BiochemistryMedicineGeneticsMolecular BiologyPharmaceutical Science
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy